Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System

In December 2020, the U.S. Food and Drug Administration licensed COVID-19 vaccines for emergency use authorization. We investigated the ocular adverse event reports in patients reported to the Vaccine Adverse Event Reporting System (VAERS) following vaccination against COVID-19. We searched the VAER...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyankerh, Cyril N. A., Boateng, Akosua K., Appah, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230098/
https://www.ncbi.nlm.nih.gov/pubmed/35746549
http://dx.doi.org/10.3390/vaccines10060941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230098/
https://www.ncbi.nlm.nih.gov/pubmed/35746549
http://dx.doi.org/10.3390/vaccines10060941

Ejemplares similares